January 22, 2026

Lyft, Inc. (LYFT) Investor Outlook: Assessing a 30.95% Potential Upside Amid Sector Challenges

Lyft, Inc. (LYFT), a prominent player in the technology sector, operates within the software application industry, providing a peer-to-peer marketplace for on-demand ridesharing in the United..

SANUWAVE Health, Inc. (SNWV)

⚠️ No article content returned.

..

Nyxoah SA (NYXH) Investor Outlook: Exploring a 137.85% Potential Upside in the Healthcare Sector

Nyxoah SA (NASDAQ: NYXH), a Belgium-based innovator in the medical technology space, is garnering interest from investors due to its robust growth potential and strategic focus..

Shopify Inc. (SHOP) Stock Analysis: A 29.56% Potential Upside and Key Analyst Ratings

Shopify Inc. (SHOP) is capturing the spotlight in the world of technology stocks, thanks to its robust market presence and significant growth potential. Trading on the..

Phathom Pharmaceuticals (PHAT): Investor Outlook on a Biotech with 68% Potential Upside

Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) is a burgeoning entity in the biotechnology sector, focusing on innovative treatments for gastrointestinal diseases. With a market capitalization of $1.06..

Viemed Healthcare, Inc. (VMD) Stock Analysis: A 73.56% Potential Upside Awaits Investors

For investors with a keen eye on growth opportunities in the healthcare sector, Viemed Healthcare, Inc. (VMD) presents an intriguing proposition. With an enticing potential upside..

UroGen Pharma Ltd. (URGN) Stock Analysis: Investors Eye 83% Upside Amid Biotech Innovations

UroGen Pharma Ltd. (NASDAQ: URGN) is making waves in the biotechnology sector, standing out with its promising innovations in urothelial and specialty cancers. With the current..

XOMA Royalty Corporation (XOMA): Investor Outlook Reveals a Compelling 136% Potential Upside

XOMA Royalty Corporation (NASDAQ: XOMA) presents an intriguing prospect for investors with a focus on the biotechnology sector. As a dedicated royalty aggregator, XOMA has carved..

Cidara Therapeutics, Inc. (CDTX) Stock Analysis: Navigating the Biotech Landscape with Potential Upside

Cidara Therapeutics, Inc. (NASDAQ: CDTX), a prominent player in the biotechnology sector, is making waves with its innovative approach to tackling serious diseases. Operating out of..

Varex Imaging Corporation (VREX) Investor Outlook: 21.55% Potential Upside and Robust Revenue Growth

For investors eyeing opportunities in the healthcare sector, Varex Imaging Corporation (NASDAQ: VREX) presents an intriguing proposition. With a market capitalization of $593.16 million, Varex operates..

Sprout Social, Inc (SPT) Stock Analysis: A Look at Its 64% Potential Upside in a Competitive Market

Sprout Social, Inc. (NYSE: SPT), with its current stock price at $9.51, presents an intriguing opportunity for investors, particularly given its potential upside of 64.04% based..

CQS Natural Resources Growth and Income double-digit NAV and share price gains in Dec 2025

CQS Natural Resources Growth and Income achieved NAV growth of 10.3% in the month, outperforming global energy and mining indices, with continued strength driven by precious..

Palvella Therapeutics, Inc. (PVLA) Stock Analysis: A Biotech Gem with 95.98% Potential Upside

Palvella Therapeutics, Inc. (PVLA), a clinical-stage biopharmaceutical company, has caught the attention of investors with its impressive potential upside of nearly 96%. Operating in the healthcare..

Gossamer Bio, Inc. (GOSS) Investor Outlook: Biotech Stock Poised for 246.72% Upside with Promising PAH Treatment

Gossamer Bio, Inc. (NASDAQ: GOSS) is a clinical-stage biopharmaceutical company that has captured the attention of investors with its innovative approach to treating pulmonary arterial hypertension..

Neurogene Inc. (NGNE) Stock Analysis: Unpacking a 222% Upside Potential in Biotechnology

Neurogene Inc. (NASDAQ: NGNE), a promising player in the biotechnology sector, is catching the attention of investors with its substantial upside potential of 222.23%. Specializing in..

Cartesian Therapeutics, Inc. (RNAC): Stock Analysis Reveals a Staggering 365% Potential Upside

Cartesian Therapeutics, Inc. (NASDAQ: RNAC) is capturing the attention of investors in the biotechnology sector, driven by its innovative approach to mRNA cell therapies for autoimmune..

Marti Technologies, Inc. (MRT): An Investor Outlook on a High-Growth, High-Upside Turkish Tech Innovator

Marti Technologies, Inc. (NASDAQ: MRT), a burgeoning player in Turkey’s urban mobility landscape, is capturing investor interest with its impressive revenue growth and substantial potential upside...

Senseonics Holdings, Inc. (SENS) Stock Analysis: Exploring the 161.64% Potential Upside in the Medical Devices Sector

Senseonics Holdings, Inc. (SENS) stands at a captivating juncture in the healthcare sector, particularly within the medical devices industry. This Germantown, Maryland-based company is making significant..

Nerdy Inc. (NRDY) Stock Analysis: Exploring a Potential 110% Upside in the EdTech Arena

Investors with an eye on the educational technology sector should take note of Nerdy Inc. (NRDY), a company that has carved out a niche in live..

Aurora Cannabis Inc. (ACB): Investor Outlook with a 48.89% Potential Upside

Aurora Cannabis Inc. (NYSE: ACB), a prominent player in the healthcare sector specializing in the production and distribution of cannabis products, presents a compelling opportunity for..

Search

Funds

January 22, 2026

CQS Natural Resources Growth and Income double-digit NAV and share price gains in Dec 2025

CQS Natural Resources Growth and Income achieved NAV growth of 10.3% in the month, outperforming global energy and mining indices, with continued strength driven by precious metals exposure...
Search

Funds

January 22, 2026

FTSE 100

Funds